- Home
- PROK vs SSP Comparison
PROK vs SSP Comparison
Compare PROK & SSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PROK | SSP |
|---|---|---|
| Founded | 2015 | 1878 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 331.2M | 301.0M |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PROK | SSP |
|---|---|---|
| Price | $2.09 | $3.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $7.40 | $5.95 |
| AVG Volume (30 Days) | ★ 844.7K | 443.4K |
| Earning Date | 02-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 108.53 |
| EPS | ★ N/A | N/A |
| Revenue | $76,000.00 | ★ $2,509,772,000.00 |
| Revenue This Year | $1,010.19 | N/A |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 9.46 |
| 52 Week Low | $0.46 | $1.36 |
| 52 Week High | $7.13 | $4.98 |
Technical Indicators
Market Signals| Indicator | PROK | SSP |
|---|---|---|
| Relative Strength Index (RSI) | 53.80 | 51.04 |
| Support Level | $1.87 | $3.30 |
| Resistance Level | $2.23 | $3.95 |
| Average True Range (ATR) | 0.16 | 0.22 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 86.47 | 51.45 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.